{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:08:12Z","timestamp":1760267292897,"version":"3.41.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.pharep.2013.12.014","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T09:06:47Z","timestamp":1397380007000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity"],"prefix":"10.1007","volume":"66","author":[{"given":"Ma\u0142gorzata","family":"Zygmunt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Sapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Ch\u0142o\u0144-Rzepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Zag\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Paw\u0142owski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2013.12.014_bib0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"Review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2013.12.014_bib0070","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/0929867013372599","article-title":"Serotonin receptor and transporter ligands \u2013 current status","volume":"8","author":"Oh","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharep.2013.12.014_bib0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1755-5922.2010.00173.x","article-title":"5-Hydroxtryptamine receptors in systemic hypertension: an arterial focus","volume":"29","author":"Watts","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.pharep.2013.12.014_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2013.12.014_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1734-1140(13)70960-5","article-title":"New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation","volume":"65","author":"Ch\u0142o\u0144-Rzepa","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.12.014_bib0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1211\/0022357021017","article-title":"Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats","volume":"55","author":"Weso\u0142owska","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.014_bib0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0004-282X2009000300007","article-title":"Use of an antagonist 5-HT2A\/C for depression and motor function in Parkinson\u2019 disease","volume":"67","author":"Werneck","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.pharep.2013.12.014_bib0065","first-page":"1083","article-title":"Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus","volume":"38","author":"Mullins","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2013.12.014_bib0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in, 5-HT7 receptor research","volume":"25","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2013.12.014_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568007043482633","article-title":"5-HT7 receptors","volume":"3","author":"Thomas","year":"2004","journal-title":"Curr Drug Targets-CNS Neurol Disord"},{"key":"10.1016\/j.pharep.2013.12.014_bib0020","first-page":"359","article-title":"Synthesis, 5-TH1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione","volume":"53","author":"Ch\u0142o\u0144","year":"2001","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.014_bib0055","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/jm030946u","article-title":"New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation","volume":"47","author":"Jurczyk","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2013.12.014_bib0040","first-page":"351","article-title":"5-HT-receptor ligands: update","volume":"2","author":"Glennon","year":"1997","journal-title":"Res Alert"},{"key":"10.1016\/j.pharep.2013.12.014_bib0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0014-827X(00)00069-0","article-title":"Synthesis, 5-HT1A and 5-HT2A receptor affinity of new 1-phenylpiperazinylpropyl derivatives of purine-2,6- and pyrrolidine-2,5-diones","volume":"55","author":"Paw\u0142owski","year":"2000","journal-title":"Il Farmaco"},{"key":"10.1016\/j.pharep.2013.12.014_bib0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/bmc.224","article-title":"Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the pre-screening of 5-HT1A ligands","volume":"17","author":"Zajdel","year":"2003","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.pharep.2013.12.014_bib0025","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1016\/j.bmc.2007.05.017","article-title":"7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT1A, 5-HT2A, and 5-HT7 serotonin receptor ligands","volume":"15","author":"Ch\u0142o\u0144-Rzepa","year":"2007","journal-title":"Bio Med Chem"},{"key":"10.1016\/j.pharep.2013.12.014_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(98)00062-4","article-title":"MDMA (\u2018Ecstasy\u2019) enhances 5HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion","volume":"346","author":"Aquirre","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.014_bib0080","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1997","journal-title":"Arch Int Pharmacodyn"},{"key":"10.1016\/j.pharep.2013.12.014_bib0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-5793(95)00828-W","article-title":"Expression of serotonin receptor mRNAs in blood vessels","volume":"370","author":"Ullmer","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharep.2013.12.014_bib0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1359-6446(97)01055-6","article-title":"Serotonin receptors as cardiovascular targets","volume":"2","author":"Villalon","year":"1997","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharep.2013.12.014_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/PL00004964","article-title":"Interactions of GR127935, a 5-HT1B\/D receptor ligand, with functional 5-HT receptors","volume":"355","author":"De-Vries","year":"1997","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.014_bib0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0701134","article-title":"Role of 5-HT7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat","volume":"121","author":"Terron","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.014_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/7854_2012_219","article-title":"Neurochemical imaging and depressive behaviours","volume":"14","author":"Meyer","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.pharep.2013.12.014_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1871524910909030197","article-title":"Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship","volume":"9","author":"Hashimoto","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.pharep.2013.12.014_bib0090","first-page":"165","article-title":"Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex","volume":"24","author":"Smith","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharep.2013.12.014_bib0115","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1734-1140(10)70315-7","article-title":"Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data","volume":"62","author":"Weso\u0142owska","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.12.014_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(11)70400-5","article-title":"Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice","volume":"63","author":"Sapa","year":"2011","journal-title":"Pharmacol Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:22Z","timestamp":1752611722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.12.014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1734114014001327"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.12.014","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2013.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}